Literature DB >> 15976357

Effects of induced hyperthyroidism in normal and cardiomyopathic hamsters.

James A Kuzman1, Tracy A Thomas, Kathryn A Vogelsang, Suleman Said, Brent E Anderson, A Martin Gerdes.   

Abstract

Thyroid hormones (TH) enhance cardiac function and reverse gene changes typical of pathological hypertrophy. However, reports in humans, but not animals, indicate that excess TH can cause heart failure. Also, the effects of TH on normal and cardiomyopathic hearts are likely to be different. The goal of this study was to characterize the effects of prolonged hyperthyroidism on cardiac function, chamber and cellular remodeling, and protein expression in both normal and cardiomyopathic hearts. Hyperthyroidism was induced in 3-mo-old normal BIO F1B and dilated cardiomyopathic BIO TO2 hamsters. After TH treatment for 10 days and 2 mo, hemodynamics, echos, myocyte length, histology, and protein expression were assessed. After 10 days and 2 mo, there were no differences between TO2-treated (Tx) and TO2-untreated (Untx) hamsters in chamber diameters or left ventricular function. After 2 mo of treatment, however, F1B-Tx showed evidence of dilated heart failure vs. F1B-Untx. Chamber diameters were increased, and ejection fraction and positive and negative changes in pressure over time were reduced. In F1B-Tx and TO2-Tx hamsters, beta-myosin isoform expression was reduced, whereas alpha-myosin increased significantly in F1B-Tx only. In TO2-Tx hamsters, the percent of viable myocardium was increased, and percent fibronecrosis was reduced vs. TO2-Untx. Myocyte length increased with TH treatment in both hamster strains. We conclude that 1) excess TH can induce heart failure in normal animals as observed in humans, 2) reversal of myosin heavy chain expression does not necessarily improve heart function, and 3) excess TH altered cellular remodeling but did not adversely affect chamber function or dimensions in TO2 hamsters.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976357     DOI: 10.1152/japplphysiol.00515.2005

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  8 in total

1.  Differential involvement of various sources of reactive oxygen species in thyroxin-induced hemodynamic changes and contractile dysfunction of the heart and diaphragm muscles.

Authors:  Mohammad T Elnakish; Eric J Schultz; Rachel L Gearinger; Nancy S Saad; Neha Rastogi; Amany A E Ahmed; Peter J Mohler; Paul M L Janssen
Journal:  Free Radic Biol Med       Date:  2015-03-17       Impact factor: 7.376

2.  Longstanding hyperthyroidism is associated with normal or enhanced intrinsic cardiomyocyte function despite decline in global cardiac function.

Authors:  Nathan Y Weltman; Dajun Wang; Rebecca A Redetzke; A Martin Gerdes
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

3.  The regulation of troponins I, C and ANP by GATA4 and Nkx2-5 in heart of hibernating thirteen-lined ground squirrels, Ictidomys tridecemlineatus.

Authors:  Bryan E Luu; Shannon N Tessier; Dianna L Duford; Kenneth B Storey
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

Review 4.  Role of Oxidative Stress in Thyroid Hormone-Induced Cardiomyocyte Hypertrophy and Associated Cardiac Dysfunction: An Undisclosed Story.

Authors:  Mohammad T Elnakish; Amany A E Ahmed; Peter J Mohler; Paul M L Janssen
Journal:  Oxid Med Cell Longev       Date:  2015-06-04       Impact factor: 6.543

5.  The Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac Abnormalities.

Authors:  Nancy S Saad; Kyle Floyd; Amany A E Ahmed; Peter J Mohler; Paul M L Janssen; Mohammad T Elnakish
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

6.  Recovery following Thyroxine Treatment Withdrawal, but Not Propylthiouracil, Averts In Vivo and Ex Vivo Thyroxine-Provoked Cardiac Complications in Adult FVB/N Mice.

Authors:  Nancy S Saad; Steven J Repas; Kyle Floyd; Paul M L Janssen; Mohammad T Elnakish
Journal:  Biomed Res Int       Date:  2017-07-16       Impact factor: 3.411

7.  Modified Low-Dose Triiodo-L-thyronine Therapy Safely Improves Function Following Myocardial Ischemia-Reperfusion Injury.

Authors:  Viswanathan Rajagopalan; Youhua Zhang; Christine Pol; Clifford Costello; Samantha Seitter; Ann Lehto; Olga V Savinova; Yue-Feng Chen; A Martin Gerdes
Journal:  Front Physiol       Date:  2017-04-12       Impact factor: 4.566

Review 8.  Focus on Autoimmune Myocarditis in Graves' Disease: A Case-Based Review.

Authors:  Lujin Wu; Wei Wang; Qianru Leng; Nana Tang; Ning Zhou; Yan Wang; Dao Wen Wang
Journal:  Front Cardiovasc Med       Date:  2021-07-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.